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The oral cavity may comprise a significant reservoir for Staphylococcus aureus but the data on 
molecular epidemiology and clonal distribution of oral strains are really scarce. This study aimed 
to evaluate the clonal relatedness in S. aureus isolated from oral cavity and their relationship with 
carriage of virulence genes, and antimicrobial resistance profiles. A total of 139 oral S. aureus isolates 
were obtained from 2327 analysed oral samples of dental patients. Antimicrobial susceptibility 
testing was performed. Isolates were characterized using protein A gene (spa) typing, spa‑CC clonal 
complexes, toxin genes and SCCmec typing for MRSA. High resistance rates for penicillin, tetracycline 
and gentamicin were detected, respectively 58.3%, 42.4%, and 35.2%. Twelve (8.6%) S. aureus 
isolates were identified as MRSA. All of MRSA isolates were mecA‑positive and mecC‑negative. 
SCCmec IV was the most common type (66.7%), which was typical for community‑acquired MRSA 
(CA‑MRSA). Overall, the enterotoxin gene cluster (egc) was the most frequent detected virulence 
factor (44.9%), both in MSSA and MRSA isolates. Presence of genes encoding for the enterotoxins 
(sea, seb, sec, seh, sek), exfoliative toxin A (eta), and toxic shock syndrome toxin‑1 (tst) was also 
observed. Strains carrying lukS-PV/lukF-PV genes belonged to SCCmecV‑ spa type t437. The most 
prevalent spa types were t091, t015, t084, t002, t571, and t026 among all 57 identified. Spa types, 
including 3 new ones, grouped in 6 different spa‑CC clonal complexes, with four major dominated; 
CC45, CC30, CC5, and CC15. This study demonstrated that both methicillin‑susceptible and methicillin‑
resistant major European clones of S. aureus could be isolated from the oral cavity of dental patients, 
with the emergence of PVL‑positive CA‑MRSA strains. The oral cavity should be considered as a 
possible source of toxigenic egc-positive S. aureus strains, in terms of potential risk of cross‑infection 
and dissemination to other body sites.
Staphylococcus aureus is responsible for a wide variety of human infections ranging from mild symptoms in 
superficial skin infections to life-threatening systemic disease, such as infective endocarditis and  sepsis1.
Staphylococcus aureus may also be associated with some oral conditions and infections in dentistry. These 
include angular cheilitis, mucositis, some endodontic infections, osteomyelitis of the jaw, and  parotitis2–4. Recent 
reports suggest that S. aureus is possibly also involved in the pathogenesis of periodontal  lesions5,6.
However, the role of S. aureus in oral infections still raises some controversies since the presence of S. aureus 
in the oral cavity has the commensal asymptomatic character in the healthy  carriers7,8. Although anterior nares 
are considered a primary ecological niche for S. aureus, it is estimated that 15–50% of persons colonized by 
these microorganisms are non-nasal  carriers9. The oral cavity is frequently colonized by S. aureus, either as a 
primary location or as a consequence of migration from the anterior  nares10,11. Recent evidence suggests that the 
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colonization may be not only transient but also  persistent12,13. According to Kearney, the oral cavity represents 
a significant and underappreciated reservoir for S. aureus10.
The oral carriage may give rise to staphylococcal infection, whether endogenous or cross-infection. Oral carri-
ers, especially immunocompromised persons, such as hemodialyzed patients, subjects with haematological malig-
nancies, rheumatoid arthritis, diabetes mellitus, etc., have increased risk of severe endogenous  infections14–17. 
According to Terpenning et al., the presence of S. aureus in saliva was a significant risk factor for aspiration 
 pneumonia18. Also, a strong relationship was found between the isolation of S. aureus and the occurrence of 
other severe infections, such as bacteraemia and infective  endocarditis19–21. As the majority of these infections are 
endogenous, the risk among S. aureus colonized patients is 11.5 times higher than in non-colonized  persons22.
Furthermore, the oral cavity may also constitute a reservoir for transmission  events23. Small et al. empha-
sized that this site can be often overlooked for screening and subsequent  decolonization24. A large body of 
evidence suggests that the transmission of S. aureus may occur between patients and dentist via the clinical 
 environment3,4,25.
Thus understanding the distribution and relatedness of staphylococcal clones colonizing oral cavity is essential 
for the strategies to control its dissemination and to reduce the incidence of  infections26.
Currently, genotyping using protein A gene (spa) typing is the most popular method for the epidemiologi-
cal analysis of S. aureus isolates, their genetic relatedness and  diversity27,28. spa typing is a useful tool for dis-
criminating S. aureus from different sources and nosocomial infection  control29. The method is based on spa 
gene polymorphism in the X-region, with variable number of 24-bp repeat sequences. The results of spa typing 
correlate with other genotyping methods, especially with worldwide used clonal grouping based on multilocus 
sequence typing (MLST)30,31.
The studies of molecular epidemiology and clonal distribution of S. aureus isolated from the oral cavity are 
really scarce. This study aimed to evaluate the clonal relatedness in S. aureus isolated from oral cavity and their 
relationship with carriage of virulence genes, as well as antimicrobial resistance profiles.
Results
Prevalence of S. aureus isolates. A total 139 S. aureus were isolated from 2327 oral samples of 750 
(18.5%) dental patients with symptoms of infection. S. aureus were detected among 128 patients, 71 females and 
57 males aged between 17 and 82 years (mean 56 years). The number of collected samples from each patients 
varied, from one sample per patients (118 patients) to two (9 patients) or three samples (1 patient). Sixty seven 
isolates derived from dorsum of the tongue swabs, 38 isolates from buccal mucosa swabs, 19 isolates from den-
ture swabs and 15 isolates from the corners of the mouth swabs.
Antimicrobial susceptibility. Overall, 139 isolates demonstrated resistance to penicillin (58.3%), tetra-
cycline (42.4%), gentamicin (35.2%), clindamycin (19.4%), erythromycin (19.4%), amoxicillin/clavulanic acid 
(16.8%), cefoxitin (8.6%), oxacillin (8.6%), chloramphenicol (4.3%), trimethoprim/sulfamethoxazole (4.3%), 
and ciprofloxacin (1.4%). None of the isolates were resistant to vancomycin. A high proportion (68%) of resist-
ance to gentamicin obtained in disk diffusion method was verified by E-tests (35.2%). D-test demonstrated that 
15.1% of isolates represented the inducible phenotype of clindamycin resistance  (MLSBi) (Table 1).
Twelve (8.6%) S. aureus isolates were identified as MRSA. All of MRSA isolates were mecA-positive, while 
none harboured mecC. Twenty-five percent of isolates showed  MLSBi resistance and this proportion was higher 
than in MSSA isolates. Resistance to tetracycline, clindamycin, erythromycin, gentamicin, and trimethoprim/
sulfamethoxazole was found in 41.7%, 25%, 25%, 16.6% and 8.3% of the MRSA isolates, respectively. All isolates 
Table 1.  Antibiotic resistance of MRSA, MSSA and the 6 spa-clonal complexes (spa-CC) of oral S. aureus 























Cefoxitin 0 100 (12) 0 9.1 (1) 0 10 (1) 40 (2) 0 < 0.001 0.072
Penicillin 54.3 (69) 100 (12) 21.4 (3) 100 (11) 40 (4) 90 (9) 60 (3) 50 (2) 0.001 0.001
Amoxicillin/cla-
vulanic acid 8.7 (11) 100 (12) 0 0 10 (1) 0 0 50( 2) < 0.001 0.003
Erythromycin 18.9 (24) 25 (3) 0 54.5 (6) 50 (5) 10 (1) 40 (2) 0 0.423 0.007
Clindamycin 4.7 (6) 0 7.1 (1) 0 10 (1) 0 0 0.441 0.742
Clindamycininda 14.2 (18) 25 (3) 0 54.5 (6) 50 (5) 10 (1) 0 0 0.391 0.002
Ciprofloxacin 1.6 (2) 0 0 0 0 0 0 0 0.661 –
Gentamicin 37 (47) 16.6 (2) 50 (7) 36.4 (4) 20 (2) 10 (1) 0 0.214 0.091
Tetracycline 42.5 (54) 41.7 (5) 7.1 (1) 81.8 (9) 30 (3) 20 (2) 40 (2) 100 (4) 0.954 < 0.001
Chloramphenicol 4.7 (6) 0 0 27.3 (3) 0 0 0 0 0.441 0.029
Trimethoprim/
sulfamethoxazole 3.9 (5) 8.3 (1) 0 0 0 0 0 0 0.424 –
Multidrug resist-
ance 26 (33) 41.7 (5) 0 63.6 (7) 40% (4) 10 (1) 0 0 0.309 0.001
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were sensitive to ciprofloxacin, chloramphenicol, and vancomycin (Table 1). Staphylococcal cassette chromosome 
mec (SCCmec) types IV (66.7%) and V (33.3%) were detected, suggesting a community origin (CA-MRSA). No 
isolate represented I, II and III SCCmec types.
Multidrug-resistance (MDR) was observed among 38 (27.3%) of all isolated S. aureus, in MRSA turned out 
to be higher (41.7%) than in MSSA (26%). MDR isolates were resistant to 3, 4 and 5 groups of antibiotics; 57.9%, 
18.4%, and 23.7% respectively.
Distribution of toxin genes. Analysis of the distribution of virulence genes among the 139 oral S. aureus 
isolates evidenced that 66.9% of them contained genes encoding toxins, with a high percentage in MRSA isolates 
(83.3%). Overall, the gene cluster egc (seg, sei, sem, sen, seo, seu) were the most common detected superantigen 
(44.9%). Genes encoding for the enterotoxins sea (9.4%), seb (3.6%), sec (12.9%), seh (2.2%), sek (3.6%), exfolia-
tive toxin A eta (2.2%), and toxic shock syndrome toxin-1 tst (7.2%) were also identified. None of the isolates 
tested positively for sed and see enterotoxin genes. Detection of the Panton-Valentine leukocidin genes (lukS-
PV/lukF-PV) (p = 0.007), the enterotoxin genes seb and sek were significantly more prevalent (16.6%) among 
MRSA than among MSSA isolates. While enterotoxin genes sea, seh, sej, sel and exfoliative toxin B gene (etb) 
were solely present in MSSA isolates, 10.2%, 2.4%, 9.4%, 4.7%, 0.8%, respectively (Table 2).
spa typing. The spa typing analysis revealed distinct 57 spa types within 139 tested S. aureus isolates, the 
most common were: t091 (10.8%), t015 (7.9%), t002 (5.0%), t012 (5.0%), t084 (4.3%), t005 (3.6%), t230 (2.9%), 
t571 (2.2%) ,t026 (2.2%). t065 (2.2%), t148 (2.2%), t160 (2.2%), and t242 (2.2%). The other spa types were less 
frequent, such as t045, t056, t085, t127, t131, t209, t437, t688, t693, t711, t1268, and t3297. The determined spa 
types included three new ones: t18952, t18953, and t18954; all of them were registered in the international data-
base, Ridom SpaServer (https ://spase rver.ridom .de/) (Table 3).
The identified spa types were clustered into six spa-clonal complexes (spa-CCs) by BURP repeat analysis; 
spa-CC 571/1451, spa-CC 021, spa-CC 084, spa-CC 888, spa-CC 015, and spa-CC 267. Forty-six (33.1%) isolates 
represented 19 spa types and belonged to singletons, ten (7.2%) isolates were excluded from BURP cluster analy-
sis due to presence of less than four spa repeats. The newly described spa types were distributed across various 
clusters and singletons (Fig. 1, Table 3).
Twelve MRSA isolates were assigned to three clonal complexes (spa-CC 084, spa-CC 888 and spa-CC 021) 
and five singletons, comprising of 9 spa types (t012, t091, t156, t189, t437, t888, t5644, t13670, t18953). Two 
isolates were excluded due to the low number of repeats. Particular attention should be given to two isolates of 
the spa type t437 having lukS-PV/lukF-PV genes as well as seb and sek (Table 3).
Overall, most isolates (10%) were assigned to the spa-CC 015 clonal complex and carried the most enterotoxin 
genes, egc (78.6%), sec (71.4%), sel, (42.8%), and sej (28.6%). egc-positive S. aureus isolates were not limited to a 
single clonal group. All isolates belonged to the spa-CC 021 also had superantigen genes, such as egc (72.7%), sea 
(72.7%) and tst (27.3%). All of them showed resistance to penicillin and most to tetracycline (81.8%). Another 
Table 2.  Prevalence of toxin genes among oral S. aureus isolates. a Genes encoding staphylococcal enterotoxins 
(sea, seb, sec, sed, see, seg, she, sei, sej, sek, sel, sem, sen, seo, seu), exfoliative toxins (eta,etb), Panton-Valentine 
leukocidin (lukS-PV/lukF-PV), and toxic shock syndrome toxin-1 (tst).
Toxin  genesa MSSA % (n = 127) MRSA % (n = 12) Total % (n = 139) p value
sea 10.2 (13) 0 9.4 (13) 0.601
seb 2.4 (3) 16.6 (2) 3.6 (5) 0.059
sec 11.8 (15) 25 (3) 12.9 (18) 0.166
sed 0 0 0 –
see 0 0 0 –
seg 44.9 (57) 41.6 (5) 44.6 (62) 0.830
seh 2.4 (3) 0 2.2 (3) 0.590
sei 44.9 (57) 41.6 (5) 44.6 (62) 0.830
sej 9.4 (12) 0 8.6 (12) 0.599
sek 2.4 (3) 16.6 (2) 3.6 (5) 0.059
sel 4.7 (6) 0 3.6 (6) 0.441
sem 42.5 (54) 33.3 (4) 41.7 (58) 0.761
sen 42.5 (54) 33.3 (4) 40.3 (56) 0.762
seo 44.1 (56) 33.3 (4) 43.2 (60) 0.553
seu 40.1 (51) 16.6 (2) 38.1 (53) 0.131
eta 1.6 (2) 8.3 (1) 2.2 (3) 0.239
etb 0.8 (1) 0 0.7 (1) 0.758
lukS-PV/lukF-PV 0 16.6 (2) 1.4 (2) 0.007
tst 7 (9) 8.3 (1) 7.2 (10) 0.873
Total 65.4 (83) 83.3 (10) 66.9 (93) 0.337
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No of cluster spa-CC MLST-CC Predicted ST spa type Toxin genes Antimicrobial resistance n
1 spa-CC 571/1451 CC 45 ST-45 t230 egc (4) P,CC,TE (1); P (2); 4
1 spa-CC 571/1451 t571 seh (1) E,CCind (2); E,CCind,GM (1) 3
1 spa-CC 571/1451 t1451 None E,CCind,GM,TE (1) 1
1 spa-CC 571/1451 t3307 None E,CCind,TE (1) 1
1 spa-CC 571/1451 t5529 sec,egc (1) P,AMC (1) 1
2 spa-CC 021 CC30 ST 30 t012 egc,tst (1); sea,egc (6) SCCmec V-FOX,P,AMC,TE, (1); P,E,CCind,TE,C (3); P,E,CCind,GM,TE (3); 7
2 spa-CC 021 CC30 ST 30 t021 sea, tst (1) P (1) 1
2 spa-CC 021 CC30 ST 30 t318 egc (1) P,TE (1) 1
2 spa-CC 021 t342 sea (1) P,GM,TE (1) 1
2 spa-CC 021 t2141 tst (1) P (1) 1
3 spa-CC084 CC15 ST15 t084 egc (1) P,E,CCind,TE (1); P (4); E (1); 6
3 spa-CC084 CC15 ST15 t085 None P,TE (1); P,GM (1) 2
3 spa-CC084 t120 None P (1) 1
3 spa-CC084 t13670 None SCCmec IV-FOX,P,AMC, (1) 1
4 spa-CC888 ST12 t156 sec (1) SCCmec IV-FOX,P,AMC, (1) 1
4 spa-CC888 ST12 t160 seb,sek (2) E,TE (2); P (1) 3
4 spa-CC888 t888 sec (1) SCCmec V-FOX,P,AMC, (1) 1
5 spa-CC015 CC45 ST45 t015 sec,egc,sej,sel (4); sec,egc,sel (1); egc,sel (1); sec (2) ;egc (3); GM,TE (1); GM (6); 11
5 spa-CC015 t630 sec (1) P,CC (1) 1
5 spa-CC015 t1268 sec,egc (2) P (2) 2
6 spa-CC267 t267 None P,AMC,TE (1) 1
6 spa-CC267 t359 None P,AMC,TE (1) 1
6 spa-CC267 t3297 None TE (2) 2
7 No founder ST121 t159 egc,eta,etb (1) P (1) 1
7 No founder t645 egc (1) P,AMC,E,TE (1) 1
8 No founder CC22 ST22 t005 egc (4) P (1); GM (2) 5
8 No founder t790 egc (1) P,TE (1) 1
9 No founder CC45 ST45 t065 egc (3) SXT (3) 3
9 No founder t560 egc (1) P (1) 1
10 No founder CC5 ST5 t002 egc (2); egc,sej (2) P,AMC (1); GM,TE,C (1); P,GM,TE (2); GM,TE (3) 7
10 No founder t242 egc,tst (3) P,TE (3) 3
11 No founder CC8 ST8 t008 sea,sej (1) P (1) 1
11 No founder t1187 None P,TE (1) 1
Singleton Singleton CC5 ST5 t045 None E,CCind,GM,TE (2) 2
Singleton Singleton ST101 t056 None GM,TE (2) 2
Singleton Singleton ST7 t091 egc (3); sej (4)
SCCmec IV-FOX,P,AMC (1); P,AMC,GM (1) 
P,GM,TE (3); P,GM (1); P,CC (1); CC,TE (1); 
P(1); CC (2); GM (3)
15
Singleton Singleton CC1 ST1 t127 seh (2) P,GM,TE (1); P,TE (1) 2
Singleton Singleton t131 None TE (2) 2
Singleton Singleton t148 egc (3) P,AMC,CC,GM (1); P,AMC (2) 3
Singleton Singleton t189 egc SCCmecIV-FOX,P,AMC,GM,TE (1) 1
Singleton Singleton ST109 t209 egc,eta (1); sea (1) P,E,CCind,TE(1); P,GM (1) 2
Singleton Singleton t254 None P,TE (1) 1
Singleton Singleton t437 seb,sek,lukS-PV/lukF-PV(2) SCCmec V-FOX,P,AMC,E,CCind (1);SCCmec V-FOX,P,AMC,TE,SXT (1) 2
Singleton Singleton t688 egc (1) E,C,TE (2) 2
Singleton Singleton t711 sea (1) GM (1) 2
Singleton Singleton t1773 None 1
Singleton Singleton t4132 None P,CIP,TE,GM,STX (2) 2
Singleton Singleton t5644 sec (2) SCCmec IV-FOX,P,AMC,GM (1) 2
Singleton Singleton t18117 seb,sek (1) TE (1) 1
Singleton Singleton 18952 tst (1) P,CC,GM (1) 1
Singleton Singleton 18953 egc (2) SCCmec IV-FOX,P,AMC (1); P,GM (1); 2
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toxigenic clonal complex, spa-CC571/1451 carried egc genes and showed inducible phenotype of erythromycin 
and clindamycin resistance. spa-CC 084 contained 7.2% of isolates, 90% of which did not have any toxin genes 
and were penicillin-resistant (Tables 3, 4, Fig. 1).
Most of isolates belonging to major MLST clonal complexes (CC45, 30, 5, and 22) were egc-positive. The 
differences in prevalence of egc-positive isolates were statistically significant (p < 0.001), as shown in Table 5.
Discussion
The epidemiology of S. aureus infections constantly changes, with novel clones emerging in various geographical 
 regions19,27,32. This warrants continuous surveillance of staphylococcal isolates from different sources, especially 
from the oral cavity. Recent evidence suggests that the latter constitutes a significant yet underrated reservoir 
of S. aureus10.
Staphylococcus aureus isolation rates differ considerably depending on the population. In healthy adults, oral 
carriage rates vary from 12 to 36%, with more frequent isolation (17–48%) among  students4,33. The carriage rate 
documented in our study (18.5%) was similar as reported by other  authors34–36, and remained within a typi-
cal range for European and American adult dental patients. It was, however, lower than in dentistry students 
examined by Ohara-Nemoto (46.6%)7, and in patients with periodontitis included in another  study6. Acrylic 
denture wearers also seem to be predisposed to the oral  carriage37, with S. aureus isolation rates of 27–48%2,38.
Nearly 9% of isolates included in this study were resistant to methicillin. The prevalence of MRSA in the oral 
cavity of adult dental patients is known to be relatively low, 5–12%2,5,36,39. Smith found MRSA strains among 6% 
Table 3.  spa types, clonal complexes, genetic profile and antimicrobial resistance of oral S. aureus isolates. 
spa-CC spa clonal complex, MLST multi-locus sequence typing, NT non-typeable, FOX cefoxitin, P penicillin, 
AMC amoxicillin/clavulanic acid, E erythromycin, CC clindamycin, CCind clindamycin inducible resistance 
 (iMLSB), CIP ciprofloxacin, GM gentamicin, TE tetracycline, C chloramphenicol, SXT trimethoprim–
sulfamethoxazole.
No of cluster spa-CC MLST-CC Predicted ST spa type Toxin genes Antimicrobial resistance n
Excluded Excluded CC45 ST45 t026 sec,egc (1); sea,tst (1) P (1); GM (1) 3
Excluded Excluded t282 egc (2) P,AMC,E,CCind (2) 2
Excluded Excluded t693 egc,eta (1); egc (1) SCCmec IV-FOX,P,AMC,E,CCind,TE, (2) 2
Excluded Excluded t1509 sec (1) 1
Excluded Excluded t17293 sec (2) 2
NT NT NT egc,sej (1); egc(1); tst (1) P,E,CCind,GM,TE (1); P,GM,TE (1); P,GM (2), P,E (1) 5
Figure 1.  Population structure of 139 S. aureus oral isolates after BURP analysis with a cost of 4. Clusters of 
linked spa types correspond to spa-CCs. The spa types that were defined as founders of particular clusters are 
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of studied patients, more often in those over 70  years39. Long-term MRSA carriage was also reported in 6 out of 
10 complete denture wearers participating in a Finnish study, and 10.3% of Asian denture  wearers38,40.
MRSA are typically isolated in a hospital setting; such hospital-acquired MRSA (HA-MRSA) are believed 
to spread primarily via human-to-human  transmission41. However, a growing number of infections caused by 
non-nosocomial MRSA, referred to as community-acquired MRSA (CA-MRSA) was also observed in the last 
 decade42,43. CA-MRSA genetically differ from HA-MRSA, are less resistant to non-β-lactam antibiotics and carry 
a smaller version of staphylococcal cassette chromosome mec (SCCmec)44,45. All MRSA isolates in this study 
harbored SCCmec type IV or V and were more susceptible to non-β-lactam antimicrobials, which suggested 
their community origin (CA-MRSA). None of the MRSA were resistant to ciprofloxacin, chloramphenicol or 
vancomycin. The proportions of strains resistant to gentamycin, clindamycin, and erythromycin were similar as 
in other types of staphylococcal  infections27,46. The analyzed MRSA showed multidrug resistance (MDR) more 
often than MSSA, which is consistent with the characteristics of MRSA  strains47,48.
spa typing demonstrated a broad genetic diversity of our staphylococcal isolates. We did not find any pub-
lished report about the clonal variety of oral S. aureus. Nevertheless, the heterogeneity observed in our series 
corresponds well with recent European and American data about MRSA involved in other  infections49,50. Rather 
than showing clustering, a typical feature of MRSA, most of our methicillin-susceptible isolates displayed exten-
sive genetic diversity. Our MSSA corresponded to major clones widespread in Poland and other European 
 countries19,49,51–54. In contrast, different predominant clonal complexes were reported in Africa and Asia, indi-
cating geographical  variation53,55,56.
The most toxigenic clonal complexes in our series were CC45, CC30 and CC22, which included the largest 
proportion of staphylococci testing positively for toxin genes in egc locus. The enterotoxin gene cluster (egc) 
encodes up to six enterotoxins (SEG, SEI, SEM, SEN, SEO, and SEU) being superantigens. The superantigens 
induce T lymphocytes and antigen-presenting cells causing massive cytokine production, with lethal effects 
dependent on direct toxic and cytokine effects on the cardiovascular  system57. Recent studies showed that egc-
clustered enterotoxins are the most prevalent virulence factors in S. aureus isolated  nowadays27,46,58. However, 
longitudinal studies are needed to better elucidate the role of locus egc in oral S. aureus strains.
The predominant clonal complex in our material was CC45, with the most common spa type being spa-
CC t015. CC45 are widely distributed among both nasal colonization and bloodstream infections strains in 
 Europe19,59, and recent results suggest that the nasal isolates carry the potential to cause an invasive  disease59. 
However, no reports on severe infections caused by oral CC45 strains have been published to date. Bonnet 
observed predominance of spaCC t015 among S. aureus associated with infective  endocarditis60, and Deasy 
pointed to this spa type as an emerging etiological factor of bloodstream  infections19. Other authors reported 
on infective endocarditis after dental extraction and treatment 61,62. These findings imply that peroral spread of 
endogenous S. aureus should be considered in at least some instances. Our findings suggest that spa-CC t015 
seems to be particularly prone to the acquisition of virulence factors, including superantigens genes, sec, sel, sej 
and egc. These findings are consistent with the data from a report on bloodstream  infections63.
The second most common clonal complex in our series was CC30. Many previous studies analyzed CC30 
strains and their link with  endocarditis64; and some authors demonstrated their role in the development of an 
invasive  disease19,20. Our spa-CC 021 belonging to CC30 clone characterized high proportion of egc-, sea-and 
tst-positive strains, especially CC30-t012, which is consistent with the results of previous  studies28,52,65. Also, 
according to an American report, CC30 strains from patients with infective endocarditis were significantly more 
Table 4.  Prevalence of toxin genes among six spa-clonal complexes (spa-CC) of oral S. aureus isolates.
Toxin genes
spa-CC 015
% (n = 14)
spa-CC 021
% (n = 11)
spa-CC 571/1451
% (n = 10)
spa-CC 084
% (n = 10)
spa-CC 888
% (n = 5)
spa-CC 267
% (n = 4) p-value
sea 0 72.7 (8) 0 0 0 0 < 0.001
seb 0 0 0 0 40 (2) 0 0.001
sec 71.4 (10) 0 10 (1) 0 40 (2) 0 < 0.001
seh 0 0 10 (1) 0 0 0 0.482
sej 28.6 (4) 0 0 0 0 0 0.030
sek 0 0 0 0 40 (2) 0 0.001
sel 42.8 (6) 0 0 0 0 0 0.002
egc 78.6 (11) 72.7 (8) 50 (5) 10 (1) 0 0 < 0.001
tst 0 27.3 (3) 0 0 0 0.029
Table 5.  Prevalence of egc-positive isolates among five major MLST clonal complexes.
Clonal complex CC45 (n = 21) CC30 (n = 9) CC5 (n = 9) CC15 (n = 8) CC22 (n = 5) Total (100% = 52)
egc-positive
strains 18 (85.7%) 8 (88.9%) 4 (44.4%) 1 (12.5%) 4 (80%) 35 (67.3%)
p value < 0.001
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likely to contain these enterotoxin genes and had the potential to cause hematogenous  complications64.The high 
resistance rates to penicillin and tetracycline was observed among our CC30 strains. To this date, resistance to 
tetracycline was not reported in S. aureus from the oral cavity but in the strains from other human or animal 
 sources66–70. However, tetracycline is also used in the treatment of some oral infections in humans, especially 
in patients with  periodontitis71. Thus, our observation on the potential emergence of tetracycline-resistant oral 
strains warrants further investigation.
To the best of our knowledge, present study was the first to demonstrate the prevalence of spa type t437 
SCCmec-V-pvl-positive S. aureus strains in dental patients. Panton-Valentine leukocidin (PVL) genes are con-
sidered a stable genetic marker for CA-MRSA strains carrying SCCmec type IV or  V72,73. More than half (66.6%) 
of strains identified in this study were assigned to SCCmec IV, whereas the strains represented spa t437 har-
bored SCCmec V. Similar strains were isolated in Germany and Taiwan, and according to a recent Polish report, 
t437 SCCmec-IV-pvl-positive strains predominated in specimens from diabetic  patients74–76. The PVL -positive 
strains were associated with purulent skin infections, necrotizing pneumonia, pyomyositis and other S. aureus 
 infections74,77–79. PV leukocidin is considered a potent inducer of inflammation and cytotoxicity but its role in 
oral infections is still little  unknown80,81.
Our study has several limitations. First, the proportion of MRSA strains was small in comparison with number 
of MSSA strains. It should be taken account in the interpretation of the results. Second, we did not analyze clinical 
data of the swabbed patients, such as type of oral infection and its manifestations. However, even considering 
these drawbacks, the results of our study add to current knowledge about oral S. aureus strains.
In conclusion, this study demonstrated that both methicillin-susceptible and methicillin-resistant S. aureus 
strains major European clones could be isolated from the oral cavity of dental patients, with the emergence 
of PVL-positive CA-MRSA strains. The oral cavity should be considered as a possible source of toxigenic egc-
positive S. aureus strains, in terms of potential risk of cross-infection and dissemination to other body sites.
Materials and methods
Isolation and identification of S. aureus. The study included oral S. aureus isolated from all 2327 oral 
microbiological samples analysed consecutively at the Laboratory of Department of Oral Microbiology of the 
Medical University of Gdansk during routine clinical laboratory procedures, over a period of three years. The 
samples were obtained with sterile cotton swabs from the oral mucosa, the dorsal surface of the tongue, denture 
surface and angular cheilitis lesions. The analysed S. aureus were not specifically isolated for this research, they 
were part of the diagnostic laboratory procedure and no humans were involved in the experiments.
All samples were plated onto Columbia blood agar (GrasoBiotech, Starogard Gd., Poland) and mannitol salt 
agar (bioMérieux, Marcy l’Etoile, France) and were incubated 18–24 h at 37 °C. Suspected staphylococcal colonies 
were identified by standard methods, on the basis of colony characteristics, pigment production, Gram-staining, 
haemolysis and Pastorex StaphPlus latex agglutination kit (Bio-Rad, Marnes la Coquette, France). Further, all 
isolates eventually identified as S. aureus based on PCR amplification of species-specific thermostable nuclease 
gene (nuc)82.
After final identification, the isolates were stored at − 80 °C in Trypticase Soy Broth (Becton Dickinson, 
Franklin Lakes, NJ, USA) supplemented with 20% glycerol.
Antimicrobial susceptibility testing. The antimicrobial susceptibility was determined on Mueller–Hin-
ton agar plates (Becton Dickinson, Franklin Lakes, NJ, USA) by the disk diffusion method and interpreted 
according to the  EUCAST83. The following antimicrobial agents were tested: oxacillin, cefoxitin, gentamicin, 
erythromycin, clindamycin, tetracycline, chloramphenicol, ciprofloxacin, amoxicillin/clavulanic acid, trimeth-
oprim/sulfamethoxazole (Bio-Rad, Marnes la Coquette, France) and penicillin G (Oxoid, Basingstoke, Eng-
land). The inducible resistance to macrolide-lincosamide-streptogramin B  (MLSB) was detected by disk dif-
fusion method with use the clindamycin (2 μg) and erythromycin (15 μg) disks positioned 15–26 mm  apart83. 
Resistance to gentamicin was verified by using E-tests (bioMérieux, Marcy l’Etoile, France), an isolate with MIC 
value > 1  µg/ml was considered as a  resistant83. Vancomycin susceptibility was determined with E-test strips 
(bioMerieux, Marcy-l’Etoile, France), in line with the manufacturer’s instruction. Multidrug resistance (MDR) 
was defined as a resistance to three or more classes of antimicrobials. Resistance to methicillin was first identified 
using cefoxitin (30 µg) and oxacillin (1 µg) disks, and then confirmed by the detection of PBP2a protein (Latex 
Agglutination Test Kit, Oxoid, Basingstoke, England), and verified by the detection of the mecA gene according 
to Khairalla et al.25 and mecC according to Stegger et al.84. S. aureus ATCC25923 (methicillin-susceptible) and S. 
aureus ATCC43300 (MDR) were used as the reference strains.
Molecular characterization. Isolation of staphylococcal DNA. Genomic Micro AX Staphylococcus 
Gravity kit (A&A Biotechnology, Gdynia, Poland) was used to isolate genomic DNA from bacteria by gravity 
according to the manufacturer’s instructions.
Detection of toxin genes. Genes of the enterotoxins (sea, seb, sec, sed, see), toxic shock syndrome toxin-1 
(tst), and exfoliative toxins (eta, etb) were detected as described by Becker et al.85, for the other enterotoxins 
genes (seg, seh, sei, sej, sek, sel, sem, sen, seo, seu) according to Bania et al.86. Detection of Panton-Valentine leu-
kocidin genes (lukS-PV/lukF-PV) was performed as described by Lina et al.87.
SCCmec typing. Typing of the five (I–V) major staphylococcal chromosomal cassette mec (SCCmec) in 
MRSA strains was determined by PCR as described by Oliveira et al.88 and by Milheiriço et al.89. The SCCmec 
type was determined on the basis of the band pattern profiles obtained.
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spa typing. The spa typing, based on amplification of the variable X region of protein A gene, was per-
formed as described  previously90. The spa types were assigned using the Ridom StaphType software version 2.2.1 
(https ://www.ridom .de/ Ridom GmbH, Wurzburg, Germany) and the Ridom SpaServer database (https ://spase 
rver.ridom .de/). The predicted MLST were assigned based on Ridom SpaServer. The based upon repeat pattern 
(BURP) algorithm was used to calculate spa clonal complexes (spa-CCs) with following parameters: (I) exclude 
spa types shorter than 5 repeats; (II) cost less or equal to 4; (III) cluster composed of 2 or more related spa types 
was regarded as CC; (IV) a spa type that was not grouped into a CC was considered as singleton.
Statistical analysis. All calculations were performed with Statistica 10 package (StatSoft, Tulsa, OK, USA). 
The significance of between-group differences in the percentages of positive isolates was verified with Pearson 
chi-squared test or Fisher exact test. The threshold of statistical significance was set at p ≤ 0.05, with Bonferroni 
correction applied whenever multiple comparisons had to be carried out.
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